OncoStem

Breast Cancer Recurrence, Early Stage 1, 2, Breast Cancer Test, India

OncoStem was founded in 2011, is headquartered in Bengaluru, India, lists 11–50 employees, and has $6.0M in recorded funding across 1 round.

Headquarters
Bengaluru
Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$6.0M
Last Round
$6.0M Series ASep 2017
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

OncoStem Diagnostics is a Bengaluru-based precision oncology company that develops AI-powered prognostic cancer tests to assess tumor aggressiveness and guide personalized treatment decisions. Founded in 2011 by Dr. Manjiri Bakre, OncoStem applies in-depth knowledge of tumor biology and machine learning to identify the unique characteristics of cancer recurrence risk in individual patients. The company's flagship product, CanAssist Breast, is a prognostic test for early-stage breast cancer (Stages 1 and 2) that helps oncologists determine whether a patient needs chemotherapy by predicting the likelihood of cancer recurrence. The test enables patients to potentially avoid the side effects of chemotherapy when their risk of recurrence is low. OncoStem is backed by Peak XV Partners (formerly Sequoia India) and is part of the broader movement to apply AI and genomics to precision diagnostics for cancer patients across India and globally.

Summary

OncoStem is a Biotech company based in Bengaluru, India, founded in 2011. It lists 11–50 employees. It has raised $6.0M in total across 1 round, most recently a $6.0M Series A round in Sep 2017. Investors include Sequoia India.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2017
$6.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OncoStem on Indexed.vc
<a href="https://indexed.vc/companies/oncostem"><img src="https://indexed.vc/api/badge/company/oncostem" alt="OncoStem on Indexed.vc" width="260" height="76" /></a>